Search

  • HOME
  • Search
Original Articles
13627
Outcome of Aflibercept-Bevacizumab Alternate Dosing in Neovascular Age-related Macular Degeneration with Limited Response to Aflibercept
Daeun Shin, Jae Hui Kim
J Korean Ophthalmol Soc. 2022;63(6):526-534.   Published online June 15, 2022
Full textFull text    PubreaderPubReader    ePubePub    CrossRef-TDMCrossref - TDM    PDFPDF    
13512
Association between Vortex Vein Engorgement and Treatment Outcomes of Intravitreal Aflibercept for Polypoidal Choroidal Vasculopathy
Areum Jeong, Min Sagong
J Korean Ophthalmol Soc. 2021;62(10):1370-1380.   Published online October 15, 2021
Full textFull text    PubreaderPubReader    ePubePub    CrossRef-TDMCrossref - TDM    PDFPDF    
13491
Limited Treatment Response during Follow-up after Switching to Aflibercept in Neovascular Age-related Macular Degeneration
Gon Soo Choe, Jong Woo Kim, Chul Gu Kim, Jae Hui Kim
J Korean Ophthalmol Soc. 2021;62(9):1218-1226.   Published online September 15, 2021
Full textFull text    PubreaderPubReader    ePubePub    CrossRef-TDMCrossref - TDM    PDFPDF    
13473
Proportion of and Reason for Bevacizumab Usage in the Treatment of Wet Age-related Macular Degeneration
Yi Sang Yoon, Won Tae Yoon, Jong Woo Kim, Chul Gu Kim, Jae Hui Kim
J Korean Ophthalmol Soc. 2021;62(8):1076-1083.   Published online August 15, 2021
Full textFull text    PubreaderPubReader    ePubePub    CrossRef-TDMCrossref - TDM    PDFPDF    
13455
Comparison of Intravitreal Bevacizumab and Aflibercept Injections for Central Serous Chorioretinopathy
Min Soo Park, Seung Joon Lee
J Korean Ophthalmol Soc. 2021;62(7):957-962.   Published online July 15, 2021
Full textFull text    PubreaderPubReader    ePubePub    CrossRef-TDMCrossref - TDM    PDFPDF    
Budget Impact Analysis of Anti-vascular Endothelial Growth Factor in Patients with Diabetic Macular Edema.
Jangmi Yang, Sang Jin Shin, Jae Kyung Suh et al.
J Korean Ophthalmol Soc. 2019;60(7):667-675.   Published online July 15, 2019
PDFPDF    
Use of Anti-vascular Endothelial Growth Factors for Diabetic Retnopathy: National Health Insurance Claims Data.
Songhee Cho, Sang Jin Shin, Jae Kyung Suh et al.
J Korean Ophthalmol Soc. 2019;60(7):661-666.   Published online July 15, 2019
PDFPDF    
Analysis of Intraocular Pressure Elevation after Intravitreal Injection of Ranibizumab and Aflibercept.
Tae Kyu Moon, Jun Young Ha, Mi Sun Sung, Sang Woo Park
J Korean Ophthalmol Soc. 2019;60(4):362-368.   Published online April 15, 2019
PDFPDF    
Meta-analysis of Intravitreal Injection of Anti-vascular Endothelial Growth Factors for Diabetic Macular Edema.
Hajin Tchoe, Sang Jin Shin, Jae Kyung Suh et al.
J Korean Ophthalmol Soc. 2019;60(2):144-151.   Published online February 15, 2019
PDFPDF    
Clinical Changes after Switching from Ranibizumab/Aflibercept to Bevacizumab in Exudative Age-related Macular Degeneration.
In Ho Lee, Jae Jung Lee, Han Jo Kwon, Sung Who Park, Ji Eun Lee
J Korean Ophthalmol Soc. 2019;60(1):40-46.   Published online January 15, 2019
PDFPDF    
Case Reports
A Case of Choroidal Osteoma with Subretinal Hemorrhage Improved by Intravitreal Bevacizumab and Aflibercept Injections.
Charm Kim, Kyung Seek Choi, Hae Jung Sun
J Korean Ophthalmol Soc. 2018;59(10):989-994.   Published online October 15, 2018
PDFPDF    
Rapid Progression of the Epiretinal Membrane after Intravitreal Aflibercept Injection.
Ji Min Kwon, Myung Shin Lee, Kang Yeun Pak, Hyun Woong Kim
J Korean Ophthalmol Soc. 2018;59(10):984-988.   Published online October 15, 2018
PDFPDF    
Original Articles
Intravitreal Aflibercept Monotherapy for Treating Submacular Hemorrhage Secondary to Neovascular Age-related Macular Degeneration.
Sue Hey Chae, Soh Eun Ahn, Hee Seong Yoon
J Korean Ophthalmol Soc. 2018;59(5):437-443.   Published online May 15, 2018
PDFPDF    
Long-term Treatment Outcome of Intravitreal Aflibercept Monotherapy for Polypoidal Choroidal Vasculopathy.
Ye Ji Kim, Sang Yun Han, Jong Woo Kim, Chul Gu Kim, Dong Won Lee, Jae Hui Kim
J Korean Ophthalmol Soc. 2018;59(3):238-245.   Published online March 15, 2018
PDFPDF    
A Comparison of Efficacies of Aflibercept and Ranibizumab, Depending on the Angiographic Classification of Polypoidal Choroidal Vasculopathy.
Gahyung Ryu, Donghyoun Noh, Junyeop Lee, Min Sagong
J Korean Ophthalmol Soc. 2017;58(12):1356-1366.   Published online December 15, 2017
PDFPDF    

Journal of
the Korean
Ophthalmological
Society

Print ISSN: 0378-6471
Online ISSN: 2092-9374



ABOUT
BROWSE ARTICLES
EDITORIAL POLICY
FOR CONTRIBUTORS
Editorial Office
SKY 1004 Building #701
50-1 Jungnim-ro, Jung-gu, Seoul 04508, Korea
Tel: +82-2-583-6520    Fax: +82-2-583-6521    E-mail: kos08@ophthalmology.org                

Copyright © 2022 by Korean Ophthalmological Society.

Developed in M2PI

Close layer
prev next